Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the In-Vitro Lung Model Market From 2025 To 2029?

In recent times, there has been an exponential growth in the market size of the in-vitro lung model, going from $0.44 billion in 2024 to $0.54 billion in 2025. This represents a compound annual growth rate (CAGR) of 21.3%. The growth recorded in the historical period is linked to the rising occurrence of respiratory diseases, increased attention to personalized healthcare, the growing interest in reusing drugs, focus on precision medicine strategies, and an increased understanding of environmental health risks.

What Is the Projected Market Size of the In-Vitro Lung Model Market?

Over the next few years, a significant expansion of the in-vitro lung model market is projected. By 2029, the value of this market is predicted to reach $1.16 billion, representing a compound annual growth rate (CAGR) of 21.0%. The anticipated market growth within this period is likely driven by factors such as the demand for drug development, a surge in preclinical testing, increased understanding of respiratory toxicology, focus on regenerative medicine, escalating environmental concerns, and a rising geriatric population. Noteworthy tendencies for this period encompass a heightened call for drug testing, the progression of 3D printing and organ-on-chip technologies, the incorporation of artificial intelligence and machine learning, the integration of sensor and monitoring tools, application diversification beyond pharmaceuticals, and the creation of disease-specific models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Who are the Major Competitors in the In-Vitro Lung Model Market Outlook?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

What Is Fueling Growth in the In-Vitro Lung Model Market?

The in vitro lung model market’s growth is anticipated to be spurred by the rise in clinical investigations. These refer to research studies examining the efficacy of novel medical methods in human subjects. The surge in these studies is fuelled by the escalating demand for sophisticated medical therapies, heightened health care requirements, and the search for innovative answers to intricate health issues. In vitro lung models contribute to clinical trials by offering a regulated setting for examining the impact of substances on lung tissue, facilitating drug trials, toxicity evaluations, disease modeling, and comprehending disease processes. For instance, according to ClinicalTrials.gov, a US-based clinical trial register, by the end of 2023, the total number of registered clinical trials worldwide was 477,230, an increase from the 437,508 trials registered in 2022. Consequently, the surge in clinical investigations is stimulating the in vitro lung model market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which In-Vitro Lung Model Market Segments Are Growing the Fastest?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Industry Trends Are Shaping the Future of the In-Vitro Lung Model Market?

Leading firms in the invitro lung model market are moving towards the construction of 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. The formation of these models involves cultivating particular respiratory cells in a specific environment, which enables them to form a structure that resembles the actual function and shape of the respiratory system. This makes for a more suitable platform for research and drug trials. For example, MatTek Corporation, a biotech company based in the US, launched EpiNasal, a novel 3D respiratory tissue model composed of primary human nasal epithelial cells, in April 2023. It successfully emulates the 3D structure and function of the nasal epithelium, inclusive of goblet cells that produce mucus, functional tight junctions, and cilia with a beating motion. The addition of EpiNasal marks an extension in MatTek’s range of 3D respiratory tissue models. This model serves as a thorough system to analyze the impact of drugs, chemicals, disease-causing agents, and consumer goods on the human respiratory system.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Countries Are Leading the In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

This Report Delivers Insight On:

1. How big is the in-vitro lung model market, and how is it changing globally?

2. Who are the major companies in the in-vitro lung model market, and how are they performing?

3. What are the key opportunities and risks in the in-vitro lung model market right now?

4. Which products or customer segments are growing the most in the in-vitro lung model market?

5. What factors are helping or slowing down the growth of the in-vitro lung model market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model